# 99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers

> **NCT02182609** · PHASE1 · COMPLETED · sponsor: **Advanced Accelerator Applications** · enrollment: 14 (actual)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **DRUG:** Kit for the Preparation of 99mTc-rhAnnexin V-128

## Key facts

- **NCT ID:** NCT02182609
- **Lead sponsor:** Advanced Accelerator Applications
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-10
- **Final completion:** 2015-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182609, "99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02182609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*